Hardcover
This book reviews advances in understanding phosphodiesterases within the central nervous system and their therapeutic applications. A range of expert authors from both academia and industry describe these, then focus on the areas of greatest scientific and medical interest to provide more detailed coverage.

Cyclic-Nucleotide Phosphodiesterases in the Central Nervous System, 1st Edition

From Biology to Drug Discovery

$368.38

  • Hardcover

    400 pages

  • Release Date

    18 April 2014

Check Delivery Options

Summary

This book reviews advances in understanding phosphodiesterases within the central nervous system and their therapeutic applications. A range of expert authors from both academia and industry describe these, then focus on the areas of greatest scientific and medical interest to provide more detailed coverage. Therapeutic and drug discovery applications are covered for diseases including Alzheimer’s, Parkinson’s, schizophrenia, erectile dysfunction, and spinal cord injuries. There is also a chapter on drug discovery tools such as in vitro assays and X-ray structures for medicinal chemistry studies.

Book Details

ISBN-13:9780470566688
ISBN-10:047056668X
Author:Nicholas J. Brandon, Anthony R. West
Publisher:John Wiley & Sons Inc
Imprint:John Wiley & Sons Inc
Format:Hardcover
Number of Pages:400
Edition:1st
Release Date:18 April 2014
Weight:726g
Dimensions:26mm x 163mm x 241mm
Series:Wiley Series in Drug Discovery and Development
A-Format
B-Format
C-Format
Cyclic-Nucleotide Phosphodiesterases in the Central Nervous System, 1st Edition by Nicholas J. Brandon - ISBN: 9780470566688
163 × 241 mm
A4
mm / in
About The Author

Nicholas J. Brandon

NICHOLAS BRANDON works at AstraZeneca within the Neuroscience Innovative Medicines Group. He has spent his career in drug discovery with a strong interest in developing phosphodiesterase inhibitors for neuropsychiatric disorders and understanding the basic mechanisms of phosphodiesterase function.

ANTHONY WEST is an Associate Professor in the Department of Neuroscience at Rosalind Franklin University. He has studied PDE function in the basal ganglia for over fifteen years, focusing on neurochemical and electrophysiological changes induced by PDE inhibitors in the healthy brain and in animal models of Parkinson’s disease and Huntington’s disease.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.